ProKidney reports $38.8 million loss in Q2 FY2023 as it advances clinical trials and prepares for Greensboro manufacturing expansion

ProKidney achieved several milestones during Q2 FY2023, such as being awarded over $34 million in incentives for a $458 million manufacturing facility in Greensboro.